Global Codeine Narcotic Market Research Report 2023

Publication ID:

PB510235171

Publication Date:

October 3, 2023

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The global Codeine Narcotic market is projected to reach US$ 965 million in 2029, increasing from US$ 681.5 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Codeine Narcotic 91制片厂.
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine's relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine's opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine's potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Codeine Narcotic market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Codeine Narcotic report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Codeine Narcotic Market Overview
1.1 Product Overview and Scope of Codeine Narcotic
1.2 Codeine Narcotic Segment by Type
1.2.1 Global Codeine Narcotic Market Value Comparison by Type (2023-2029)
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Codeine Narcotic Segment by Application
1.3.1 Global Codeine Narcotic Market Value by Application: (2023-2029)
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Codeine Narcotic Market Size Estimates and Forecasts
1.4.1 Global Codeine Narcotic Revenue 2018-2029
1.4.2 Global Codeine Narcotic Sales 2018-2029
1.4.3 Global Codeine Narcotic Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Codeine Narcotic Market Competition by Manufacturers
2.1 Global Codeine Narcotic Sales Market Share by Manufacturers (2018-2023)
2.2 Global Codeine Narcotic Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Codeine Narcotic Average Price by Manufacturers (2018-2023)
2.4 Global Codeine Narcotic Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Codeine Narcotic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Codeine Narcotic, Product Type & Application
2.7 Codeine Narcotic Market Competitive Situation and Trends
2.7.1 Codeine Narcotic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Codeine Narcotic Players Market Share by Revenue
2.7.3 Global Codeine Narcotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Codeine Narcotic Retrospective Market Scenario by Region
3.1 Global Codeine Narcotic Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Codeine Narcotic Global Codeine Narcotic Sales by Region: 2018-2029
3.2.1 Global Codeine Narcotic Sales by Region: 2018-2023
3.2.2 Global Codeine Narcotic Sales by Region: 2024-2029
3.3 Global Codeine Narcotic Global Codeine Narcotic Revenue by Region: 2018-2029
3.3.1 Global Codeine Narcotic Revenue by Region: 2018-2023
3.3.2 Global Codeine Narcotic Revenue by Region: 2024-2029
3.4 North America Codeine Narcotic Market Facts & Figures by Country
3.4.1 North America Codeine Narcotic Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Codeine Narcotic Sales by Country (2018-2029)
3.4.3 North America Codeine Narcotic Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Codeine Narcotic Market Facts & Figures by Country
3.5.1 Europe Codeine Narcotic Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Codeine Narcotic Sales by Country (2018-2029)
3.5.3 Europe Codeine Narcotic Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Codeine Narcotic Market Facts & Figures by Country
3.6.1 Asia Pacific Codeine Narcotic Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Codeine Narcotic Sales by Country (2018-2029)
3.6.3 Asia Pacific Codeine Narcotic Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Codeine Narcotic Market Facts & Figures by Country
3.7.1 Latin America Codeine Narcotic Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Codeine Narcotic Sales by Country (2018-2029)
3.7.3 Latin America Codeine Narcotic Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Codeine Narcotic Market Facts & Figures by Country
3.8.1 Middle East and Africa Codeine Narcotic Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Codeine Narcotic Sales by Country (2018-2029)
3.8.3 Middle East and Africa Codeine Narcotic Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Codeine Narcotic Sales by Type (2018-2029)
4.1.1 Global Codeine Narcotic Sales by Type (2018-2023)
4.1.2 Global Codeine Narcotic Sales by Type (2024-2029)
4.1.3 Global Codeine Narcotic Sales Market Share by Type (2018-2029)
4.2 Global Codeine Narcotic Revenue by Type (2018-2029)
4.2.1 Global Codeine Narcotic Revenue by Type (2018-2023)
4.2.2 Global Codeine Narcotic Revenue by Type (2024-2029)
4.2.3 Global Codeine Narcotic Revenue Market Share by Type (2018-2029)
4.3 Global Codeine Narcotic Price by Type (2018-2029)
5 Segment by Application
5.1 Global Codeine Narcotic Sales by Application (2018-2029)
5.1.1 Global Codeine Narcotic Sales by Application (2018-2023)
5.1.2 Global Codeine Narcotic Sales by Application (2024-2029)
5.1.3 Global Codeine Narcotic Sales Market Share by Application (2018-2029)
5.2 Global Codeine Narcotic Revenue by Application (2018-2029)
5.2.1 Global Codeine Narcotic Revenue by Application (2018-2023)
5.2.2 Global Codeine Narcotic Revenue by Application (2024-2029)
5.2.3 Global Codeine Narcotic Revenue Market Share by Application (2018-2029)
5.3 Global Codeine Narcotic Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Taiji
6.1.1 Taiji Corporation Information
6.1.2 Taiji Description and Business Overview
6.1.3 Taiji Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Taiji Codeine Narcotic Product Portfolio
6.1.5 Taiji Recent Developments/Updates
6.2 Mallinckrodt
6.2.1 Mallinckrodt Corporation Information
6.2.2 Mallinckrodt Description and Business Overview
6.2.3 Mallinckrodt Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Mallinckrodt Codeine Narcotic Product Portfolio
6.2.5 Mallinckrodt Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.3.4 TEVA Codeine Narcotic Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson & Johnson Codeine Narcotic Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Medreich
6.5.1 Medreich Corporation Information
6.5.2 Medreich Description and Business Overview
6.5.3 Medreich Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Medreich Codeine Narcotic Product Portfolio
6.5.5 Medreich Recent Developments/Updates
6.6 Sanofi Aventis
6.6.1 Sanofi Aventis Corporation Information
6.6.2 Sanofi Aventis Description and Business Overview
6.6.3 Sanofi Aventis Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sanofi Aventis Codeine Narcotic Product Portfolio
6.6.5 Sanofi Aventis Recent Developments/Updates
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cipla Codeine Narcotic Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Corporation Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hikma Codeine Narcotic Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Pharmaceutical Associates
6.9.1 Pharmaceutical Associates Corporation Information
6.9.2 Pharmaceutical Associates Description and Business Overview
6.9.3 Pharmaceutical Associates Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pharmaceutical Associates Codeine Narcotic Product Portfolio
6.9.5 Pharmaceutical Associates Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Novartis Codeine Narcotic Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Corporation Information
6.11.2 Apotex Codeine Narcotic Description and Business Overview
6.11.3 Apotex Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Apotex Codeine Narcotic Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Mylan
6.12.1 Mylan Corporation Information
6.12.2 Mylan Codeine Narcotic Description and Business Overview
6.12.3 Mylan Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Mylan Codeine Narcotic Product Portfolio
6.12.5 Mylan Recent Developments/Updates
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Corporation Information
6.13.2 Aristo Pharma GmbH Codeine Narcotic Description and Business Overview
6.13.3 Aristo Pharma GmbH Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Aristo Pharma GmbH Codeine Narcotic Product Portfolio
6.13.5 Aristo Pharma GmbH Recent Developments/Updates
6.14 Lannett Company
6.14.1 Lannett Company Corporation Information
6.14.2 Lannett Company Codeine Narcotic Description and Business Overview
6.14.3 Lannett Company Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Lannett Company Codeine Narcotic Product Portfolio
6.14.5 Lannett Company Recent Developments/Updates
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Corporation Information
6.15.2 Laboratoire Riva Codeine Narcotic Description and Business Overview
6.15.3 Laboratoire Riva Codeine Narcotic Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Laboratoire Riva Codeine Narcotic Product Portfolio
6.15.5 Laboratoire Riva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Codeine Narcotic Industry Chain Analysis
7.2 Codeine Narcotic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Codeine Narcotic Production Mode & Process
7.4 Codeine Narcotic Sales and Marketing
7.4.1 Codeine Narcotic Sales Channels
7.4.2 Codeine Narcotic Distributors
7.5 Codeine Narcotic Customers
8 Codeine Narcotic Market Dynamics
8.1 Codeine Narcotic Industry Trends
8.2 Codeine Narcotic Market Drivers
8.3 Codeine Narcotic Market Challenges
8.4 Codeine Narcotic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.